BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a naturally occurring protective protein found in human gastric juice. With a sequence of 15 amino acids, it has demonstrated remarkable stability and multi-system activity in preclinical research — making it one of the most studied peptides in the recovery and regenerative category.
What Is BPC-157?
BPC-157 was first isolated from human gastric juice, where the parent protein plays a cytoprotective role in the GI tract. The synthetic fragment (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, corresponding to positions 98–112 of gastric juice protein) is resistant to enzymatic degradation and can be administered systemically.
Unlike many peptides, BPC-157 remains stable in gastric acid, which has led researchers to study both oral and parenteral administration routes. This stability profile makes it uniquely accessible as a research compound.
Mechanism of Action
BPC-157 operates through several overlapping mechanisms:
Nitric Oxide (NO) System: Research has consistently shown BPC-157 modulates NO production, which plays a critical role in vascular tone, inflammation, and tissue healing. It appears to upregulate eNOS (endothelial nitric oxide synthase) activity in damaged tissue.
Angiogenesis: BPC-157 strongly promotes the formation of new blood vessels through upregulation of VEGF (Vascular Endothelial Growth Factor). This is likely a key driver of its tissue repair effects — new vasculature means oxygen and nutrients reach damaged areas faster.
Growth Hormone Receptor Interaction: Studies suggest BPC-157 can sensitize tissue to growth hormone signaling, even without elevating GH levels directly. This may explain accelerated healing in connective tissue models.
Tendon and Ligament Fibroblast Stimulation: BPC-157 has been shown to increase collagen synthesis and fibroblast proliferation in tendon and ligament cultures, providing a direct mechanistic explanation for its widely studied musculoskeletal effects.
Key Research Findings
Musculoskeletal Repair: In rodent models, BPC-157 has demonstrated accelerated healing of transected Achilles tendons, crushed muscles, and damaged ligaments. Recovery timelines were significantly shortened compared to controls, with histological analysis confirming improved tissue quality.
Gastrointestinal Protection: Consistent with its origin in gastric juice, BPC-157 has shown remarkable protection against GI damage from NSAIDs, alcohol, and experimental ulceration. It has also been studied in inflammatory bowel disease models with promising results.
Neurological Activity: Several studies have examined BPC-157 in CNS contexts — including dopamine system modulation, neuroprotection following traumatic brain injury, and spinal cord injury recovery models. These findings are earlier-stage but intriguing.
Systemic Tolerance: Across hundreds of preclinical studies, BPC-157 has shown no reported toxicity at doses studied, and no mutagenic potential in standard assays.
Research Administration Routes
Preclinical research has examined multiple routes:
- Intraperitoneal (IP): Most common in rodent studies. Provides rapid systemic distribution.
- Subcutaneous (SC): Used in many studies as a more translationally relevant route.
- Intragastric/Oral: Particularly relevant for GI studies. BPC-157 retains bioactivity despite gastric acid exposure.
- Local injection: Some studies have applied BPC-157 directly to injury sites (tendon, muscle) with positive results.
Dose ranges in preclinical literature vary widely by model and route. Researchers should refer to specific published protocols relevant to their research model.
Research Considerations
BPC-157 is exclusively intended for laboratory and preclinical research purposes. It has not been approved by any regulatory body for human therapeutic use. The majority of evidence comes from rodent studies; human clinical data remains extremely limited. Researchers should design experiments with appropriate controls and consult the primary literature for methodological guidance.
Published References
Research Use Only. All content is for informational and educational purposes regarding preclinical research. None of the compounds discussed have been approved by the FDA for human therapeutic use. This information does not constitute medical advice.